Universal-Beteiligungs- und Servicegesellschaft’s Avadel Pharmaceuticals AVDL Stock Holding History

Universal-Beteiligungs- und Servicegesellschaft’s Portfolio AVDL Stock Details AVDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-10,033	Closed	-$153K	–	2068
2025 Q3	$153K	Buy	+10,033	New	+$131K	﹤0.01%	2033

Other funds holding AVDL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GJL

Gendell Jeffrey L $11.3B AUM 163.06% 1-Year Est. Return

WAM

Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return

Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft's AVDL Position: Q4 2025 in Review

Universal-Beteiligungs- und Servicegesellschaft sold out of Avadel Pharmaceuticals (AVDL) in Q4 2025, closing a stake of 10,033 shares — an estimated $153K sold.

Universal-Beteiligungs- und Servicegesellschaft first reported a position in AVDL in Q3 2025 and held it in 1 quarter. The position peaked at $153K in Q3 2025. 207 funds tracked by Wall St. Rank hold AVDL as of Q4 2025.

Universal-Beteiligungs- und Servicegesellschaft reported no remaining Avadel Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
Universal-Beteiligungs- und Servicegesellschaft sold 10,033 Avadel Pharmaceuticals shares in Q4 2025, an estimated $153K.
Universal-Beteiligungs- und Servicegesellschaft first reported a position in Avadel Pharmaceuticals in Q3 2025 and held it in 1 quarter.
Universal-Beteiligungs- und Servicegesellschaft's Avadel Pharmaceuticals position peaked at $153K in Q3 2025.
207 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q4 2025.

Based on Universal-Beteiligungs- und Servicegesellschaft's 13F filing for Q4 2025, filed 28 Jan 2026.